Market Overview
The global periodontal disease market is projected to grow from USD 3,712.97 million in 2023 to USD 6,256.85 million by 2032, at a compound annual growth rate (CAGR) of 5.76% during the forecast period.
The market growth is primarily driven by the increasing prevalence of periodontal conditions, especially as the aging population rises, alongside growing awareness about the importance of oral health. Advancements in diagnostic technologies and minimally invasive treatment options have also contributed significantly to market expansion. Additionally, the increasing adoption of preventive dental care and oral hygiene products is fueling the demand for treatments related to periodontal disease. With an increasing focus on cosmetic dentistry, many individuals are seeking solutions to address aesthetic concerns related to gum health. Furthermore, trends such as the integration of artificial intelligence (AI) in dental diagnostics and treatment planning, alongside the increasing use of laser therapy, are expected to improve patient outcomes and experience. The expansion of advanced periodontal care services in emerging markets, along with the development of cost-effective treatment solutions, is expected to further bolster market growth.
Market Drivers
Rising Awareness of Oral Health
Public health campaigns emphasizing the importance of oral hygiene and its link to systemic health have led to a rise in public awareness. Mass media campaigns have been shown to improve oral health behaviors and knowledge, resulting in more frequent dental visits. Social media and online resources have further contributed to this awareness by encouraging individuals to take preventive measures and seek timely treatments for periodontal disease. The widespread distribution of oral health information is empowering people to make informed decisions, which is directly driving the demand for dental care services, including treatments for periodontal disease.
Market Challenges Analysis
Lack of Awareness and Limited Access to Dental Care
A major challenge to addressing periodontal disease is the lack of awareness, particularly in developing countries. Many individuals in these regions are unaware of the symptoms and long-term consequences of periodontal disease. For instance, a study found that awareness of the link between periodontal disease and systemic health is limited in both urban and rural areas in India, leading to delays in diagnosis and treatment. Inadequate oral hygiene practices, combined with limited access to dental care, exacerbate the problem, contributing to the widespread prevalence of periodontal disease. Many people in underserved regions face obstacles such as a lack of access to dental professionals due to geographic or socioeconomic factors. This, coupled with insufficient education on the importance of oral health and preventive care, further hinders efforts to combat periodontal disease.
Market Segmentation
By Type
Gingivitis
Chronic Periodontal Disease
Aggressive Periodontal Disease
Others
By Application
Non-surgical Treatment
Surgical Treatment
By Therapeutics
Systemic Antibiotics
Local Antibiotics
By End Users
Hospitals
Dental Clinics
Dental Academics
Research Institutes and Others
By Distribution Channel
Distribution Channel 1
Distribution Channel 2
Distribution Channel 3
Distribution Channel 4
By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Spain
Russia
Belgium
Netherlands
Austria
Sweden
Poland
Denmark
Switzerland
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
Australia
Thailand
Indonesia
Vietnam
Malaysia
Philippines
Taiwan
Rest of Asia Pacific
Latin America
Brazil
Argentina
Peru
Chile
Colombia
Rest of Latin America
Middle East & Africa
UAE
KSA
Israel
Turkey
Iran
Rest of Middle East
Egypt
Nigeria
Algeria
Morocco
Rest of Africa
Key Player Analysis
Bausch Health Companies Inc.
Colgate-Palmolive Company
Mylan N.V.
Lyne Laboratories
WOCKHARDT
Xttrium Laboratories
Sunstar Suisse S.A.
3M
Izun Pharmaceuticals
Tolmar Pharmaceuticals, Inc.
- CHAPTER NO. 1 : INTRODUCTION
- 1.1.1. Report Description
- Purpose of the Report
- USP & Key Offerings
- 1.1.2. Key Benefits for Stakeholders
- 1.1.3. Target Audience
- 1.1.4. Report Scope
- CHAPTER NO. 2 : EXECUTIVE SUMMARY
- 2.1. Periodontal Disease Market Snapshot
- 2.1.1. Periodontal Disease Market, 2018 - 2032 (USD Million)
- CHAPTER NO. 3 : Periodontal Disease Market – INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Porter’s Five Forces Analysis
- CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE
- 4.1. Company Market Share Analysis – 2023
- 4.2. Periodontal Disease Market Company Revenue Market Share, 2023
- 4.3. Company Assessment Metrics, 2023
- 4.4. Start-ups /SMEs Assessment Metrics, 2023
- 4.5. Strategic Developments
- 4.6. Key Players Product Matrix
- CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS
- CHAPTER NO. 6 : Periodontal Disease Market – BY Based on Type ANALYSIS
- CHAPTER NO. 7 : Periodontal Disease Market – BY Based on Application ANALYSIS
- CHAPTER NO. 8 : Periodontal Disease Market – BY Based on Therapeutics ANALYSIS
- CHAPTER NO. 9 : Periodontal Disease Market – BY Based on End Users ANALYSIS
- CHAPTER NO. 10 : Periodontal Disease Market – BY Based on Distribution Channel ANALYSIS
- CHAPTER NO. 11 : Periodontal Disease Market – BY Based on the Geography ANALYSIS
- CHAPTER NO. 12 : COMPANY PROFILES
- 12.1. Bausch Health Companies Inc.
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
- 12.1.3. Swot Analysis
- 12.1.4. Business Strategy
- 12.1.5. Financial Overview
- 12.2. Colgate-Palmolive Company
- 12.3. Mylan N.V.
- 12.4. Lyne Laboratories
- 12.5. WOCKHARDT
- 12.6. Xttrium Laboratories
- 12.7. Sunstar Suisse S.A.
- 12.8. 3M
- 12.9. Izun Pharmaceuticals
- 12.10. Tolmar Pharmaceuticals, Inc.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook